Summary
Techniques are described for growth of primary human tumor colony-forming units in agar in glass capillary tubes. Tissue recovered from an invasive procedure is made into a single cell suspension. The cells are washed and placed in tissue culture media and agar in glass capillary tubes. After 10 to 14 d of incubation, colonies of tumor cells are visible in the capillaries. This technique can be used to determine the sensitivity pattern of patients' tumors to conventional and investigational anticancer agents. The technique can also be used to screen for antitumor activity of new chemical entities.
Similar content being viewed by others
V. References
Alberts, D. S.; Chen, H. S.; Soehnlen, B. S., et al.In vitro clonogenic assay for predicting response to ovarian cancer to chemotherapy. Lancet 2:340–342; 1980.
Ali-Osman, F.; Beltz, P. A. Optimization and characterization of the capillary human tumor clonogenic cell assay. Cancer Res. 48:715–724; 1988.
Ali-Osman, F.; Maurer, H. R.; Bier, J.In vitro cytostatic drug sensitivity testing in the human tumor stem cell assay: a modified method for the determination of the sensitivity index. Tumor Diagn. Ther. 4:1–6; 1983.
Buick, R. N.; Fry, S. E.; Salmon, S. E. Application ofin vitro soft agar technique for growth of tumor cells to the study of colon cancer. Cancer 45:1238–1242; 1980.
Buick, R. N.; Stanisic, T. H.; Fry, S. F., et al. Development of an agarmethyl cellular clonogenic assay for cells in transitional cell carcinoma of the human bladder. Cancer Res. 39:5051–5056; 1979.
Carney, D. N.; Gazdar, A. F.; Minna, J. D. Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small cell carcinoma of the lung. Stem Cells 1:149–206; 1982.
Epstein, L. B.; Shen, J. T.; Abele, J. S., et al. Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by anin vitro semisolid agar technique. Ann. NY Acad. Sci. 350P:228–247; 1980.
Hamburger, A.; Salmon, S. E. Primary bioassay of human myeloma stem cells. J. Clin. Invest. 60:846–854; 1977.
Hamburger, A.; Salmon, S. E. Primary bioassay of human myeloma stem cells. Science 197:461–463; 1977.
Hamburger, A. W.; Salmon, S. E.; Kim, M. B., et al. Direct cloning of human ovarian carcinoma cells in agar. Cancer Res. 38:3438–3444; 1978.
Hanauske, A-R.; Hanauske, U.; Buchok, J., et al. Recombinant human transforming growth factor alpha stimulatesin vitro colony formation of fresh human tumor specimens. Int. J. Cell Cloning 6:221–229; 1988.
Hutton, J. J.; Von Hoff, D. D. Cytotoxicity of 2-chlorodeoxyadenosine in a human tumor colony-forming assay. Cancer Drug Delivery 3:115–122; 1986.
Jones, S. F.; Hamburger, A. W.; Kim, M. B., et al. Development of a bioassay for putative human lymphoma stem cells. Blood 53:294–303; 1979.
Lathan, B.; Diehl, V.; Clark, G. M., et al. Cytotoxic activity of 9-β-D-arabinofuranosy1-2, fluoruadenine 5 monophosphate (Fludarabine, NSC312887) in a human tumor cloning system. Eur. J. Cancer Clin. Oncol. 24:1891–1895; 1988.
Loesch, D. M.; Von Hoff, D. D.; Page, C. P., et al. Direct cloning of human adenocarcinoma of the colon in soft agar: relationship to Duke's Stage at time of diagnosis and degree of differentiation. Stem Cells 1:313; 1982.
Mattox, D. E.; Von Hoff, D. D. Culture of human head and neck cancer stem cells using soft agar. Arch. Otolaryngol. 106:672–674; 1980.
Mattox, D. E.; Von Hoff, D. D.In vitro stem cell assay in head and neck squamous carcinoma. Am. J. Surg. 140:527–530; 1980.
Meyskens, F. L., Jr. Human melanoma colony formation in soft agar. In: Salmon. S., ed. Cloning of human tumor stem cells. NY: Alan Liss; 1980:85–99.
Meyskens, F. L., Jr.; Salmon, S. E. Inhibition of human melanoma colony formation by retinoids. Cancer Res. 39:4055–4057; 1979.
Ogawa, M.; Bergsagel, D. E.; McCulloch, E. A. Chemotherapy of mouse myeloma: quantitative cell cultures predictive of responsein vivo. Blood 41:7–15; 1973.
Ozols, R. F.; Wilson, J. K. U.; Weltz, M. D., et al. Inhibition of human ovarian cancer colony formation by adriamycin and its major metabolites. Cancer Res. 40:4109–4112; 1980.
Park, C. H.; Bergsagel, D. E.; McCulloch, E. A. Mouse myeloma tumor stem cells: a primary cell culture assay. JNCI 46:411–422; 1971.
Pavelic. Z. P.; Slocum, H. K.; Rustum, Y. M., et al. Colony growth in soft agar of human melanoma, sarcoma and lung carcinoma cells disaggregated by mechanical and enzymatic methods. Cancer Res. 40:2160–2164; 1980.
Pavelic, Z. P.; Slocum, H. K.; Rustum, Y. M., et al. Growth of cell colonies in soft agar from biopsies of different human solid tumors. Cancer Res. 40:4151–4158; 1980.
Perkins, T.; Von Hoff, D. D. Experience with a two layer soft agar system for growing gastronintestinal malignancies. In: Straelin, J. R.; Romsdahl, M. M., eds. New York: Raven Press, 1981:381–389.
Pollard, E. B.; Tio, F.; Myers, J. W. Utilization of a human tumor cloning system to monitor for marrow involvement with small cell carcinoma of the lung. Cancer Res. 41:1015–1020; 1981.
Rosenblum, M. L.; Knebel, K. D.; Vasquez, D. A. Brain tumor therapy: quantitative analysis using a model system. J. Neurosurg. 46:145–154; 1977.
Rosenblum, M. L.; Vasquez, D. A.; Hoshine, T., et al. Development of a clonogenic cell assay for human brain tumors. Cancer 41:2305–2314; 1978.
Salmon, S. E.; Alberts, D. S.; Durie, B. G. M., et al. Clinical correlations of drug sensitivity in the human tumor stem cell assay. Recent Results Cancer Res. 74:300–305; 1980.
Salmon, S. E.; Hamburger, A. W.; Soehnle, B., et al. Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N. Engl. J. Med. 298:1323–1327; 1978.
Sarosdy, J. F.; Lamm, D. L.; Radwin, H. M., et al. Assay for clonogenic cells of human genitourinary cancer. Surg. Forum 31:583–585; 1980.
Sarosdy, M. F.; Lamm, D. L.; Radwin, H. M., et al. Clonogenic assay andin vitro chemosensitivity testing of human urologic malignancies. Cancer 50:1332–1338; 1982.
Selby, P.; Buick, R. N.; Tannock. I. A critical appraisal of the human tumor stem cell assay. N. Engl. J. Med. 308:129–134; 1983.
Shoemaker, R. H.; Wolpert-Defillipes, M. K.; Kern, D. H., et al. Application of a human tumor colony-forming assay to new drug screening. Cancer Res. 45:2145–2153; 1985.
Taylor, C. W.; Alberts, D. S.; Ketcham, M. A., et al. Clinical pharamacology of a novel diarylsulfonylurea antitumor agent. J. Clin. Oncol. 7:1733–1740; 1989.
Von Hoff, D. D. He's not going to talk aboutin vitro predictive assays again, is he? JNCI 82:46–101; 1990.
Von Hoff, D. D. Human tumor cloning assays: applications in clinical oncology and new antineoplastic agent development. Cancer Metast. Rev. 7:357–371; 1988.
Von Hoff, D. D. In vitro predictive testing: the sulfonamide era. Int. J. Cell Cloning. 5:179–190; 1987.
Von Hoff, D. D. New leads from the laboratory for treating testicular cancer. In: Van Sterem, A. T., ed. Therapeutic program in ovarian cancer, testicular cancer, and sarcomas. Boston:Martin Hijhoff; 1980:225–234.
Von Hoff, D. D. Send this patient's tumor for culture and sensitivity? N. Engl. J. Med. 308:154–155; 1983.
Von Hoff, D. D.; Casper, J.; Bradley, E., et al. Association between human tumor colony forming assay results and response of an individual patient's tumor to chemotherapy. Am. J. Med. 70:1027–1032; 1981.
Von Hoff, D. D.; Casper, J.; Bradley, E., et al. Direct cloning of human neuroblastoma cells in soft agar culture. Cancer Res. 40:3591–3597; 1980.
Von Hoff, D. D.; Clark, G. M.; Stogdill, B. J., et al. Prospective clinical trial of a human tumor cloning system. Cancer Res. 43:1926–1931; 1983.
Von Hoff, D. D.; Coltman, C. A., Jr.; Forseth, B. Activity of mitoxantrone in a human tumor cloning system. Cancer Res. 41:1853–1855; 1981.
Von Hoff, D. D.; Cowan, J.; Harris, G., et al. Human tumor cloning on feasibility and clinical correlations. Cancer Chemother. Pharmacol. 6:265–271; 1981.
Von Hoff, D. D.; Forseth, B.; Harrison, G., et al. Direct cloning of human malignant melanoma in soft agar culture. Cancer 50:84–89; 1982.
Von Hoff, D. D.; Forseth, B. J.; Huong, M., et al. Improved plating effeciencies for human tumors cloned in capillary tubes versus petri dishes. Cancer Res. 46:4012–4017; 1986.
Von Hoff, D. D.; Harris, G. J.; Johnson, G., et al. Initial experience the human tumor stem cell assay system: potential and problems. In: Salmon, S., ed. Cloning of human tumor stem cells. NY: Alan R. Liss; 1980:113–124.
Von Hoff, D. D.; Huong, A. M. Effect of recombinant beta interferon (rIFN-β 34r ) on primary human tumor colony forming units. J. Interferon Res. 8:813–820; 1988.
Von Hoff, D. D.; Sandbach, J. F.; Clark, G. M., et al. Selection of cancer chemotherapy for a patient by anin vitro assay versus a clinician. JNCI 82:110–116; 1990.
Von Hoff, D. D.; Sandbach, J.; Osborne, C. K., et al. Potential and problems with growth of breast cancer in a human tumor cloning system. Breast Cancer Res. Treat. 1:141–148; 1981.
Von Hoff, D. D.; Sarosy, G.; Brown, T. D., et al. Rationale for and conduct of a phase I clinical trial with interferon alpha-2b plus doxorubicin. Semin. Oncol. 13:72–77; 1986.
Von Hoff, D. D., Weisenthal, L.In vitro methods to predict for patient response to chemotherapy. In: Garattini, S.; Goldin, A.; Hawkins, F., et al., eds. Advances in pharmacology and chemotherapy, vol. 12. New York: Academic Press; 1980:133–156.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Von Hoff, D.D., Marshall, M., Chacon, D. et al. Cloning of primary human tumor colony forming units in glass capillaries. Journal of Tissue Culture Methods 13, 125–131 (1991). https://doi.org/10.1007/BF01666143
Issue Date:
DOI: https://doi.org/10.1007/BF01666143